Search

everythinglearnresearchcommunity

for

Search:↓

Older adults still engage in sexual activities but face challenges like health issues and lack of professional support, highlighting the need for better healthcare provider education and research on sexual fulfillment in old age.

The conclusion is that more research is needed to better understand and treat adult acne, and that patient education and simple treatment plans are important for better results.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

People with hair loss often have lower levels of zinc and copper in their blood.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

The document concludes that accurate diagnosis and appropriate management are crucial for treating various hair disorders, which have significant psychological impacts.

Combining synthetic and herbal treatments may help with hair loss, but more research is needed.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Finasteride effectively treats mild to moderate hair loss in men aged 18-41, with some side effects.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Chitosan-decorated finasteride nanosystems improve skin retention and could be a better treatment for hair loss.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Finasteride worsens heart damage from nandrolone decanoate but protects against cell damage.

Exposure to the hair loss drug finasteride during pregnancy can cause genital anomalies in male babies, but not in female babies. It's best to avoid this drug in women who could potentially become pregnant.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Justicia procumbens extract may help prevent hair loss and improve hair thickness and shine in a type of hair loss condition.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.